enVVeno Medical (NVNO) Long-Term Deferred Tax (2020 - 2021)
enVVeno Medical (NVNO) recorded quarterly Long-Term Deferred Tax of $14.5 million in Q4 2021, up 35.24% quarter-over-quarter from $10.7 million in Q4 2020, and up 35.24% on a YoY basis from $10.7 million in Q4 2020.
enVVeno Medical (NVNO) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends
enVVeno Medical's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $14.5 million for Q4 2021.
- In Q4 2021, Long-Term Deferred Tax rose 35.24% year-over-year to $14.5 million; the TTM figure through Dec 2021 stood at $14.5 million (up 35.24% YoY), while the FY2021 annual figure was $14.5 million, up 35.24% from the prior year.
- Long-Term Deferred Tax was $14.5 million for Q4 2021 at enVVeno Medical, up from $10.7 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $14.5 million in Q4 2021 to a low of $10.7 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | enVVeno Medical | 6.86 Mn | 6.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 14.48 Mn |
| Dec 31, 2020 | 10.71 Mn |